Combining clinical expertise and experience with the vast and ever-increasing knowledge of artificial intelligence has the ...

An anticancer medication called TLD1433, a ruthenium(II) complex that has entered Phase II trials for conditions such as ...

A new study from the University of Kansas details how U.S. tobacco corporations expanded into global food markets from the ...

Artificial intelligence (AI) is rapidly reshaping medicine, from diagnosing disease to accelerating drug discovery. Its ...

In May 2026, Pennsylvania Gov. Josh Shapiro's administration filed suit against Character Technologies Inc., the company ...

A new study has uncovered how antidepressants affect different groups of serotonin-producing brain cells in opposite ways, ...

Researchers racing to develop a vaccine to fight the growing Ebola outbreak centered in the Democratic Republic of the Congo ...

A new study to be presented at the SLEEP 2026 annual meeting found that patients at high risk for obstructive sleep apnea who ...

Mayo Clinic researchers and collaborators have shown that artificial intelligence (AI) can analyze routine pathology slides ...

A pilot study published today in Communications Medicine demonstrates the potential of a new approach to treating anorexia ...

A new report in the American Journal of Human Genetics describes a novel disorder caused by biallelic loss-of-function ...

By inducing specific patterns of activity in small portions of the brain in awake mice, researchers have triggered a ...